COMPASS THERAPEUTICS, INC. Operating Leases, Future Minimum Payments, Remainder of Fiscal Year
COMPASS THERAPEUTICS, INC. (CMPX) had Operating Leases, Future Minimum Payments, Remainder of Fiscal Year of $481.00 thousand as of 2020-09-30, per its 10-Q filed 2020-11-09.
Discontinued › Notes › Leases
us-gaap:OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear · last filed 2020-11-09
- 2020-09-30: Operating Leases, Future Minimum Payments, Remainder of Fiscal Year $481.00K.
- 2020-06-30: Operating Leases, Future Minimum Payments, Remainder of Fiscal Year $962.00K.
| Period end | Operating Leases, Future Minimum Payments, Remainder of Fiscal Year |
|---|---|
| 2020-09-30 | $481.00K 10-Q · filed 2020-11-09 |
| 2020-06-30 | $962.00K 10-Q · filed 2020-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |